Global MRNA Synthesis Raw Material Market 2024-2028
The mRNA synthesis raw material market is forecasted to grow by USD 776.45 mn during 2023-2028, accelerating at a CAGR of 4.93% during the forecast period. The report on the mRNA synthesis raw material market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic and infectious diseases, advancements in mRNA technology, and the advantages of mRNA vaccines.
Technavio's MRNA synthesis raw material market is segmented as below:
By Application
- Vaccine production
- Therapeutics production
- Others
By End-user
- Biopharmaceutical and pharmaceutical companies
- CROs and CMOs
- Academic and research institutions
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the collaborations in biotechnology and manufacturing processes related to mRNA synthesis as one of the prime reasons driving the mRNA synthesis raw material market growth during the next few years. Also, growing demand for sustainable and environmentally friendly raw materials and increasing R and D investments by pharmaceutical and biopharmaceutical companies will lead to sizable demand in the market.
The report on the MRNA synthesis raw material market covers the following areas:
- mRNA synthesis raw material market sizing
- mRNA synthesis raw material market forecast
- mRNA synthesis raw material market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mRNA synthesis raw material market vendors that include Bayer AG, BioNTech SE, BOCSCI Inc., CELONIC Group, Corden Pharma International GmbH, Creative Biolabs, CureVac AG, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, HONGENE, Jena Bioscience GmbH, Lonza Group Ltd., Maravai LifeSciences Holdings Inc., Merck KGaA, New England Biolabs Inc., Pfizer Inc., Promega Corp., Samsung Electronics Co. Ltd., Thermo Fisher Scientific Inc., and Yeasen Biotechnology Co. Ltd.. Also, the mRNA synthesis raw material market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.